CN104287045A - 一种大清枣茶菌饮品 - Google Patents
一种大清枣茶菌饮品 Download PDFInfo
- Publication number
- CN104287045A CN104287045A CN201410621418.4A CN201410621418A CN104287045A CN 104287045 A CN104287045 A CN 104287045A CN 201410621418 A CN201410621418 A CN 201410621418A CN 104287045 A CN104287045 A CN 104287045A
- Authority
- CN
- China
- Prior art keywords
- zizyphus maurtiana
- large green
- juice
- tea
- tea fungus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000233866 Fungi Species 0.000 title abstract description 15
- 235000013361 beverage Nutrition 0.000 title abstract description 11
- 241001122767 Theaceae Species 0.000 title abstract 12
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims abstract description 27
- 235000013616 tea Nutrition 0.000 claims abstract description 27
- 239000002994 raw material Substances 0.000 claims abstract description 19
- 201000010099 disease Diseases 0.000 claims abstract description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 6
- 239000001963 growth medium Substances 0.000 claims abstract description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 5
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 5
- 241001247821 Ziziphus Species 0.000 claims description 78
- 235000019225 fermented tea Nutrition 0.000 claims description 31
- 241000894006 Bacteria Species 0.000 claims description 22
- 244000269722 Thea sinensis Species 0.000 claims description 17
- 235000013399 edible fruits Nutrition 0.000 claims description 11
- 235000006468 Thea sinensis Nutrition 0.000 claims description 8
- 230000001580 bacterial effect Effects 0.000 claims description 8
- 235000020279 black tea Nutrition 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 5
- 238000000855 fermentation Methods 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 241000607479 Yersinia pestis Species 0.000 claims description 3
- 238000010564 aerobic fermentation Methods 0.000 claims description 3
- 230000004151 fermentation Effects 0.000 claims description 3
- 230000035800 maturation Effects 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 13
- 230000036541 health Effects 0.000 abstract description 6
- 235000009508 confectionery Nutrition 0.000 abstract description 3
- 235000016709 nutrition Nutrition 0.000 abstract description 3
- 239000003814 drug Substances 0.000 abstract description 2
- 235000019629 palatability Nutrition 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract description 2
- 235000019640 taste Nutrition 0.000 abstract description 2
- 230000008821 health effect Effects 0.000 abstract 2
- 230000000295 complement effect Effects 0.000 abstract 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 21
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 8
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 5
- 229930003231 vitamin Natural products 0.000 description 5
- 235000013343 vitamin Nutrition 0.000 description 5
- 239000011782 vitamin Substances 0.000 description 5
- 229940088594 vitamin Drugs 0.000 description 5
- 150000003722 vitamin derivatives Chemical class 0.000 description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 4
- 229930091371 Fructose Natural products 0.000 description 4
- 239000005715 Fructose Substances 0.000 description 4
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 230000001093 anti-cancer Effects 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 239000004310 lactic acid Substances 0.000 description 4
- 235000014655 lactic acid Nutrition 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 3
- 208000007882 Gastritis Diseases 0.000 description 3
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 241000235342 Saccharomycetes Species 0.000 description 3
- 208000034189 Sclerosis Diseases 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 210000001367 artery Anatomy 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 229960001948 caffeine Drugs 0.000 description 3
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000000174 gluconic acid Substances 0.000 description 3
- 235000012208 gluconic acid Nutrition 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 150000008442 polyphenolic compounds Chemical class 0.000 description 3
- 235000013824 polyphenols Nutrition 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 229940097043 glucuronic acid Drugs 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 230000003387 muscular Effects 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 235000008935 nutritious Nutrition 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000009182 swimming Effects 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- FTVWIRXFELQLPI-ZDUSSCGKSA-N (S)-naringenin Chemical compound C1=CC(O)=CC=C1[C@H]1OC2=CC(O)=CC(O)=C2C(=O)C1 FTVWIRXFELQLPI-ZDUSSCGKSA-N 0.000 description 1
- 208000012657 Atopic disease Diseases 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 244000012254 Canarium album Species 0.000 description 1
- 235000009103 Canarium album Nutrition 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- DSLZVSRJTYRBFB-LLEIAEIESA-N D-glucaric acid Chemical compound OC(=O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O DSLZVSRJTYRBFB-LLEIAEIESA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 208000012895 Gastric disease Diseases 0.000 description 1
- 206010017886 Gastroduodenal ulcer Diseases 0.000 description 1
- 206010018045 Gastroptosis Diseases 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 206010019663 Hepatic failure Diseases 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- 241000220225 Malus Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 241000220324 Pyrus Species 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 206010047612 Vitamin B2 deficiency Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 208000004631 alopecia areata Diseases 0.000 description 1
- AEMOLEFTQBMNLQ-BKBMJHBISA-N alpha-D-galacturonic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-BKBMJHBISA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 201000007590 ariboflavinosis Diseases 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000007177 brain activity Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- -1 carrotene Chemical compound 0.000 description 1
- 208000023652 chronic gastritis Diseases 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000021022 fresh fruits Nutrition 0.000 description 1
- 235000020553 functional juice drink Nutrition 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 231100000029 gastro-duodenal ulcer Toxicity 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 231100000835 liver failure Toxicity 0.000 description 1
- 208000007903 liver failure Diseases 0.000 description 1
- 230000000527 lymphocytic effect Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229940117954 naringenin Drugs 0.000 description 1
- WGEYAGZBLYNDFV-UHFFFAOYSA-N naringenin Natural products C1(=O)C2=C(O)C=C(O)C=C2OC(C1)C1=CC=C(CC1)O WGEYAGZBLYNDFV-UHFFFAOYSA-N 0.000 description 1
- 235000007625 naringenin Nutrition 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 235000021017 pears Nutrition 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 208000004223 riboflavin deficiency Diseases 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
- A23L2/382—Other non-alcoholic beverages fermented
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
一种大清枣茶菌饮品。具体包括：以大青枣为主要原料制备大青枣汁，然后再以大青枣汁为培养基，以红糖为碳源，用红茶菌为菌源，制备出一种新型特色的大青枣菌茶饮料。通过实施本发明，将大青枣和红茶菌有机结合起来，所组合起来的营养物质更加丰富；大青枣和红茶菌对人体疾病都具有显著的保健功效，二者合二为一后，其功效再相辅相成，而形成的茶饮料其保健功效更为彰显。其综合效果远超单纯大青枣品种及传统的红茶菌饮料。同时，制备出来的大青枣红茶菌饮品产品形态理想，容易消化吸收，口感酸甜适口，适口性非常好，适用人群极为广泛，是一种兼备饮料及有医药功效的双重功能生态保健饮品，市场前景非常好。
Description
技术领域
本发明属于一种功能性果汁饮品的制备技术领域，具体涉及一种大清枣茶菌饮品。
背景技术
青枣，水果类，有“热带小苹果”“维生素丸”之美称。其果形优美而具苹果、梨、枣的风味。青枣是一种优良的热带、亚热带珍稀水果。台湾青枣果实营养丰富，脆甜可口，含有大量维生素C、钙、磷、维生素B、胡萝卜素等，有“日食三枣，长生不老”之说。青果重50-100克，甜度10-20度，每百克青枣含蛋白质1.2克、脂肪0.3克、碳水化合物23.7克，含有丰富的维生素和多种微量元素。
营养价值：
(1)增强人体免疫力大枣含有大量的糖类物质，主要为葡萄糖，也含有果糖、蔗糖，以及由葡萄糖和果糖组成的低聚糖、阿拉伯聚糖及半乳醛聚糖等；并含有大量的维生素C、核黄素、硫胺素、胡萝卜素、尼克酸等多种维生素，具有较强的补养作用，能提高人体免疫功能，增强抗病能力。
(2)增强肌力，增加体重实验小鼠每日灌服大枣煎剂，共3周，体重的增加较对照组明显升高，并且在游泳试验中，其游泳时间较对照组明显延长，这表明大枣有增强肌力和增加体重的作用。
(3)保护肝脏有实验证实，对四氯化碳肝损伤的家兔，每日喂给大枣煎剂共1周，结果血清总蛋白与白蛋白较对照组明显增加，表明大枣有保肝作用。
(4)抗过敏大枣乙醇提取物对特异反应性疾病，能抑制抗体的产生，对小鼠反应性抗体也有抑制作用，提示大枣具有抗变态反应作用。
(5)镇静安神大枣中所含有黄酮-双-葡萄糖甙A有镇静、催眠和降压作用，其中被分离出的柚配质C糖甙类有中枢抑制作用，即降低自发运动及刺激反射作用、强直木僵作用，故大枣具有安神、镇静之功。
(6)抗癌，抗突变大枣含多种三该类化合物，其中烨木酸、山植酸均发现有抗癌活性，对肉瘤S-180有抑制作用。枣中所含的营养素，能够增强人体免疫功能，对于防癌抗癌和维持人体脏腑功能都有一定效果。
目前，大清枣主要是以新鲜水果生食。而关于用大青枣进行深加工未见相关报道。
发明内容
本发明的目的就是提供全新的一种大清枣茶菌饮品。具体包括：以大青枣为主要原料制备大青枣汁，然后再以大青枣汁为培养基，以红糖为碳源，用红茶菌为菌源，制备出一种新型特色的大青枣红茶菌饮品。
所述的红茶菌是以茶水、糖为原料，经醋酸菌、酵母菌和乳酸菌等多种微生物共同发酵而成的。其中，红茶菌菌液中含有一部分茶叶的浸出物、活的微生物及其代谢产物，这些物质主要包括葡萄糖酸、醋酸、葡萄糖、果糖、蛋白质、氨基酸、维生素、微量元素、茶多酚、咖啡因、乙醇和二氧化碳等。红茶菌还富含维生素C、维生素B等营养素，并含有多种对人体有益的微生物，因此能调节人体生理机能，促进新陈代谢，帮助消化，防止动脉硬化，抗癌，养生强身，成为一种盛行全世界的养生保健饮料。
红茶菌在中国流传应用已有150余年的历史，近些年国内外医学界应用红茶菌的实践表明，红茶菌能治疗多种慢性疾病，如高血压、动脉硬化、冠心病、糖尿病、便秘、痔疮、肥胖症、斑秃、白发、白内障、风湿性关节炎、胃炎、痢疾、贫血、核黄素缺乏等。
根据营养分析，红茶菌饮料主要营养成分及相应的功能如下：
(1)多糖、茶多酚、低聚异麦芽糖、茶碱：提高人体免疫力，增强自身抵抗力；调节血脂，调节血糖；促进双歧杆菌生长，减少肠道腐败物质和致癌物质；增加T-淋巴细胞和B-淋巴细胞的数量，提高机体的防御能力。
(2)醋酸、乳酸、柠檬酸：清理肠胃，帮助消化，防治便秘，提高维生素的稳定性，预防有害病菌、病毒入侵，预防感冒。
(3)咖啡因：提高大脑活力，消除疲劳，振作精神。
(4)红茶菌中含有三种对人体有益的益生菌：酵母菌，醋酸菌和乳酸菌。对人体可起到特殊的保健作用。
(5)清理肠胃，消毒解毒，通畅大便，杀灭有害病菌，增加有益菌落，适用于急慢性胃炎，肠炎，便秘，顽固性便秘消除，顽固性腹泻，痢疾等痊愈。
(6)调理肠胃，食欲不振这增加饮食，饭量大增，营养不良者可恢复健康，特别是可使城乡最常见最难治的胃溃疡，十二指肠胃溃疡，胃下垂等胃病痊愈，反胃，呕吐，反酸水等症状消失。
(7)现代医学证明，醋酸具有消除疲劳、增强食欲、帮助消化、防治高血压和动脉硬化的作用，还具有一定的抗肿瘤、防肥胖，使钙易于被人体吸收、保持骨骼的柔韧以及润肌嫩肤的作用。
(8)肝脏障碍排除，急慢性肝炎、肝硬化痊愈。许多人认为红茶菌的解毒抗癌功能因子之一是葡萄糖醛酸，它是人体肝脏中最主要的解毒物质之一。
(9)红茶菌中存在的葡萄糖二酸1，4内酯可使肝素、透明质酸、硫酸粘多糖以及葡萄糖醛酸的破坏大大减少，帮助身体更有效地排出毒素，防癌抗癌，并缓解关节炎、痛风、气喘和相关组织功能下降所引起的其它不适。
(10)痔疮软化消失，更年期功能障碍减少。红茶菌中的葡萄糖酸能与重金属结合形成水溶性复合物，帮助人体排出有害的重金属元素。有研究表明新的红茶菌饮用者尿中的重金属含量增加。
本发明是通过以下技术方案来实现的：
一种大清枣茶菌饮品，技术方案中在于：以大青枣为主要原料制备大青枣汁，然后再以大青枣汁为培养基，以红糖为碳源，用红茶菌为菌源，制备出一种新型特色的大青枣红茶菌饮品。
1、所述的大青枣汁制备方法如下：
(1)原料选择：采集无病虫害、无变质、8～9成熟的大青枣为原料；
(2)大青枣处理：将大青枣清洗干净，并将果实进行且剥，及果籽去除，然后切分成小块的果肉；
(3)原料配比：大青枣果肉1份、清水10份；
(4)打浆：将上述大青枣果肉和清水混合在一起，然后打成浆汁并过滤而得大青枣汁。
2、所述的大青枣红茶菌饮品制备方法如下：
(1)原料组成及配比：大青枣汁100份、红糖5份、红茶菌种2份；
(2)发酵：将上述大青枣汁、红糖、红茶菌种放置在干净的塑料桶里，并将三种原料搅拌均匀，使红糖完全溶解于溶液之中，最后按照常规方法进行好氧发酵；
(3)成品：将大青枣汁发酵至溶液的PH为3.5～4.5而得成品大青枣红茶菌饮品。
本发明既有如下优点：
1、本发明所提出的大青枣红茶菌饮品其制备方法不但构思新颖，而且配方简单，加工工艺亦很简单，容易实施。
2、实施本发明所用的主要原料——大青枣，该原料不但资源丰富，而且容易组织，同时价格低廉。重要的是大青枣营养丰富，还具有众多的保健功效，是一种绿色天然的养生水果品种。
3、制备本发明的菌源——红茶菌，该菌种具有培育方法简单、菌种形成周期短、生产成本低廉、菌种质量稳定等有点；红茶菌中主要含有三种对人体特别有益的益生菌：酵母菌、醋酸菌和乳酸菌，对人体可起到特殊的保健作用；同时，由于红茶菌是用茶叶制备的茶液作为培养基，所以菌液中含有一部分茶叶的浸出物、活的微生物及其代谢产物，这些物质主要包括葡萄糖酸、醋酸、葡萄糖、果糖、蛋白质、氨基酸、维生素、微量元素、茶多酚、咖啡因、乙醇和二氧化碳等。因此，红茶菌不但富含有多种对人体有益的微生物，还含有多种营养物质，能调节人体生理机能、促进新陈代谢、帮助消化、防止动脉硬化、抗癌、养生强身等。
4、通过实施本发明，将大青枣和红茶菌有机结合起来，所组合起来的营养物质更加丰富；大青枣和红茶菌对人体疾病都具有显著的保健功效，二者合二为一后，其功效再相辅相成，而形成的茶饮料其保健功效更为彰显。其综合效果远超单纯大青枣品种及传统的红茶菌饮料。
5、通过实施本发明，所制备出来的大青枣菌茶饮料口感酸甜适口，适口性非常好，是一种兼备饮料及有医药功效的双重功能生态保健饮品。
6、通过实施本发明，制备而成的大青枣菌茶饮料成本非常低，但由于该饮料营养丰富、保健效果好、物美价廉，适用人群极为广泛，所以市场前景非常好。
7、本发明制作出来的产品形态理想，产品很好地保留了大青枣原有的营养和功能成分，容易消化吸收，增强了特殊功能；改变了目前市场上大青枣加工产品稀少的现状，解决了大青枣的产后出路，并带动大青枣相关产业的发展，形成新的经济增长点，具有巨大的经济效益和社会效益。
具体实施方式
下面结合实施例对本发明的方法进一步说明。
一种大清枣茶菌饮品，技术方案中在于：以大青枣为主要原料制备大青枣汁，然后再以大青枣汁为培养基，以红糖为碳源，用红茶菌为菌源，制备出一种新型特色的大青枣红茶菌饮品。
具体实施方式如下：
1、制备大青枣汁：
(1)原料选择：采集无病虫害、无变质、8～9成熟的大青枣为原料；
(2)大青枣处理：将大青枣清洗干净，并将果实进行且剥，及果籽去除，然后切分成小块的果肉；
(3)原料配比：大青枣果肉1份、清水10份；
(4)打浆：将上述大青枣果肉和清水混合在一起，然后打成浆汁并过滤而得大青枣汁。
2、制备大青枣红茶菌饮品：
(1)原料组成及配比：大青枣汁100份、红糖5份、红茶菌种2份；
(2)发酵：将上述大青枣汁、红糖、红茶菌种放置在干净的塑料桶里，并将三种原料搅拌均匀，使红糖完全溶解于溶液之中，最后按照常规方法进行好氧发酵；
(3)成品：将大青枣汁发酵至溶液的PH为3.5～4.5而得成品大青枣红茶菌饮品。
Claims (1)
1.一种大清枣茶菌饮品，其特征在于：以大青枣为主要原料制备大青枣汁，然后再以大青枣汁为培养基，以红糖为碳源，用红茶菌为菌源，制备出一种新型特色的大青枣红茶菌饮品；
所述的大青枣汁制备方法如下：
(1)原料选择：采集无病虫害、无变质、8～9成熟的大青枣为原料；
(2)大青枣处理：将大青枣清洗干净，并将果实进行且剥，及果籽去除，然后切分成小块的果肉；
(3)原料配比：大青枣果肉1份、清水10份；
(4)打浆：将上述大青枣果肉和清水混合在一起，然后打成浆汁并过滤而得大青枣汁；
所述的大青枣红茶菌饮品制备方法如下：
(1)原料组成及配比：大青枣汁100份、红糖5份、红茶菌种2份；
(2)发酵：将上述大青枣汁、红糖、红茶菌种放置在干净的塑料桶里，并将三种原料搅拌均匀，使红糖完全溶解于溶液之中，最后按照常规方法进行好氧发酵；
(3)成品：将大青枣汁发酵至溶液的PH为3.5～4.5而得成品大青枣红茶菌饮品。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410621418.4A CN104287045A (zh) | 2014-11-07 | 2014-11-07 | 一种大清枣茶菌饮品 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410621418.4A CN104287045A (zh) | 2014-11-07 | 2014-11-07 | 一种大清枣茶菌饮品 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104287045A true CN104287045A (zh) | 2015-01-21 |
Family
ID=52307213
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410621418.4A Pending CN104287045A (zh) | 2014-11-07 | 2014-11-07 | 一种大清枣茶菌饮品 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104287045A (zh) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106036328A (zh) * | 2016-06-28 | 2016-10-26 | 黄秀英 | 一种大青枣灵芝液体菌种转化饮品 |
| CN106107347A (zh) * | 2016-06-28 | 2016-11-16 | 黄秀英 | 一种大青枣桑黄液体菌种转化饮品 |
| CN106107346A (zh) * | 2016-06-28 | 2016-11-16 | 黄秀英 | 一种大青枣虫草液体菌种转化饮品 |
| CN106173767A (zh) * | 2016-08-23 | 2016-12-07 | 施安乐 | 一种发酵型印度枣金珠果复合饮料及其制备工艺 |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1586328A (zh) * | 2004-10-11 | 2005-03-02 | 王�义 | 红茶菌饮料的生产方法 |
| CN1593252A (zh) * | 2004-07-15 | 2005-03-16 | 天津科技大学 | 红枣红茶菌饮料及其酿制方法 |
| CN101843346A (zh) * | 2010-03-23 | 2010-09-29 | 福建师范大学 | 发酵法制备红茶菌果汁饮料的方法 |
| CN102389134A (zh) * | 2011-11-07 | 2012-03-28 | 钟麒 | 一种红茶菌复合发酵饮料及制备方法 |
| CN102461953A (zh) * | 2010-11-08 | 2012-05-23 | 重庆市黔江区黔双科技有限公司 | 青枣饮料的制作方法 |
| CN103040055A (zh) * | 2012-12-10 | 2013-04-17 | 孙福 | 一种青枣饮料的制作方法 |
| CN103798890A (zh) * | 2014-02-21 | 2014-05-21 | 聊城大学 | 一种红茶菌苹果醋及其制作方法 |
| CN103892259A (zh) * | 2012-12-29 | 2014-07-02 | 宁国中科生物科技有限公司 | 一种水东青枣保健食品及其制备方法 |
-
2014
- 2014-11-07 CN CN201410621418.4A patent/CN104287045A/zh active Pending
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1593252A (zh) * | 2004-07-15 | 2005-03-16 | 天津科技大学 | 红枣红茶菌饮料及其酿制方法 |
| CN1586328A (zh) * | 2004-10-11 | 2005-03-02 | 王�义 | 红茶菌饮料的生产方法 |
| CN101843346A (zh) * | 2010-03-23 | 2010-09-29 | 福建师范大学 | 发酵法制备红茶菌果汁饮料的方法 |
| CN102461953A (zh) * | 2010-11-08 | 2012-05-23 | 重庆市黔江区黔双科技有限公司 | 青枣饮料的制作方法 |
| CN102389134A (zh) * | 2011-11-07 | 2012-03-28 | 钟麒 | 一种红茶菌复合发酵饮料及制备方法 |
| CN103040055A (zh) * | 2012-12-10 | 2013-04-17 | 孙福 | 一种青枣饮料的制作方法 |
| CN103892259A (zh) * | 2012-12-29 | 2014-07-02 | 宁国中科生物科技有限公司 | 一种水东青枣保健食品及其制备方法 |
| CN103798890A (zh) * | 2014-02-21 | 2014-05-21 | 聊城大学 | 一种红茶菌苹果醋及其制作方法 |
Non-Patent Citations (3)
| Title |
|---|
| 方心芳 等: "茶菌—一种保健饮料", 《生物学通报》 * |
| 王春霞 等: "红茶菌枣饮料的研制及副产物的利用", 《食品工业科技》 * |
| 陈胜慧子: "红枣红茶菌发酵饮料的研制", 《饮料工业》 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106036328A (zh) * | 2016-06-28 | 2016-10-26 | 黄秀英 | 一种大青枣灵芝液体菌种转化饮品 |
| CN106107347A (zh) * | 2016-06-28 | 2016-11-16 | 黄秀英 | 一种大青枣桑黄液体菌种转化饮品 |
| CN106107346A (zh) * | 2016-06-28 | 2016-11-16 | 黄秀英 | 一种大青枣虫草液体菌种转化饮品 |
| CN106173767A (zh) * | 2016-08-23 | 2016-12-07 | 施安乐 | 一种发酵型印度枣金珠果复合饮料及其制备工艺 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104305427A (zh) | 葡萄红茶菌饮料 | |
| CN104304560A (zh) | 一种甜茶红茶菌 | |
| CN104336719A (zh) | 一种枸杞红茶菌饮料 | |
| CN104382164A (zh) | 一种灵芝红茶菌 | |
| CN104304578A (zh) | 一种火龙果菌茶 | |
| CN104304577A (zh) | 一种以金花茶为载体的生物型饮料及其制备方法 | |
| CN104287040A (zh) | 以百香果为原料制备生物型饮料 | |
| CN104351887A (zh) | 一种桑葚茶菌 | |
| CN104273271A (zh) | 一种荷花红茶菌饮料 | |
| CN104287046B (zh) | 一种以花生为主要原料的生物型饮料 | |
| CN104287045A (zh) | 一种大清枣茶菌饮品 | |
| CN104304589A (zh) | 一种铁皮石斛茶菌 | |
| CN104273612A (zh) | 一种甘蔗生物型饮品 | |
| CN104382129A (zh) | 一种甜玉米红茶菌饮品 | |
| CN104273613A (zh) | 一种芒果茶菌饮料 | |
| CN104351900A (zh) | 一种以糯米为原料的生物型饮料及其制备方法 | |
| CN104273628A (zh) | 以薏米为原料的生物饮料及其制备方法 | |
| CN104287039A (zh) | 一种以糙米为原料的生物饮料及其制备方法 | |
| CN104287044A (zh) | 一种猕猴桃红茶菌饮品 | |
| CN104304561A (zh) | 一种桑黄菌丝红茶菌饮料 | |
| CN104286281A (zh) | 一种西瓜红茶菌饮料 | |
| CN104305429A (zh) | 一种发酵型黄秋葵茶饮料 | |
| CN104286280A (zh) | 一种木瓜红茶菌饮品 | |
| CN104273611A (zh) | 一种番茄茶菌饮料 | |
| CN104432367A (zh) | 一种以墨米为原料的生物型饮料及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150121 |